Janney Capital Management LLC trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 48,656 shares of the biopharmaceutical company’s stock after selling 5,774 shares during the […]
Private Wealth Management Group LLC acquired a new position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 3,009 shares of the biopharmaceutical company’s stock, valued at approximately $154,000. A number of […]
Great Lakes Advisors LLC trimmed its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 26.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,260,589 shares of the biopharmaceutical company’s stock after selling 457,616 shares during the quarter. Great Lakes […]
First City Capital Management Inc. decreased its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 2.3% in the fourth quarter, Holdings Channel.com reports. The firm owned 25,561 shares of the biopharmaceutical company’s stock after selling 614 shares during the period. First City Capital Management Inc.’s holdings in Bristol-Myers Squibb were worth $1,312,000 at the […]
Loudon Investment Management LLC reduced its holdings in Ameriprise Financial, Inc. (NYSE:AMP – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,627 shares of the financial services provider’s stock after selling 94 shares during the quarter. Ameriprise […]
Loudon Investment Management LLC cut its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 24,693 shares of the company’s stock after selling 758 shares during the quarter. AbbVie makes up approximately 2.4% […]
Loudon Investment Management LLC decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 1.1% during the 4th quarter, Holdings Channel reports. The institutional investor owned 13,992 shares of the medical research company’s stock after selling 150 shares during the quarter. Amgen makes up approximately 2.5% of Loudon Investment Management LLC’s portfolio, […]
Pettee Investors Inc. lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 0.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 71,920 shares of the biopharmaceutical company’s stock after selling 476 shares during the quarter. Bristol-Myers Squibb accounts for […]
Investment Management Associates Inc. ADV decreased its holdings in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 25.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,869 shares of the biopharmaceutical company’s stock after selling 6,789 shares during the quarter. […]
Trillium Asset Management LLC trimmed its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.5% in the 4th quarter, HoldingsChannel.com reports. The fund owned 144,502 shares of the company’s stock after selling 3,776 shares during the period. Trillium Asset Management LLC’s holdings in Procter & Gamble were worth $21,176,000 […]
Vanguard Personalized Indexing Management LLC cut its holdings in The Cigna Group (NYSE:CI – Free Report) by 12.8% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 24,915 shares of the health services provider’s stock after selling 3,664 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in The Cigna Group were worth […]
Mid American Wealth Advisory Group Inc. raised its stake in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.7% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 78,261 shares of the biopharmaceutical company’s stock after buying an additional 2,794 shares during the quarter. Bristol-Myers Squibb makes up about […]